UCB's Global Corporate Website

This section is intended for media and financial analysts

Search Press releases

25 Sep 2006

UCB - video interview

Read More
25 Sep 2006

UCB ANNOUNCES PROPOSED ACQUISITION OF SCHWARZ PHARMA FOR CASH AND SHARES, VALUING SCHWARZ PHARMA AT 4.4 BILLION EUROS

Read More
15 Sep 2006

UCB Awards Professorial Chair in Management of Inflammatory Bowel Disease at the Katholieke Universiteit Leuven, Belgium

Read More
23 Aug 2006

FDA Approves Keppra® as Adjunctive Therapy in the Treatment of Myoclonic Seizures in Patients with Juvenile Myoclonic Epilepsy

Read More
21 Aug 2006

UCB Announces Agreement with Verus Pharmaceuticals for Commercialization of Twinject® in Europe

Read More
18 Aug 2006

Key Approval for Keppra® Offers New Treatment Option for Newly Diagnosed Epilepsy Patients

Read More

Stay up-to-date on the latest news and information from UCB